Valvular Heart Disease: What Your Patients Should Know
What should patients know about valvular heart disease, the forms it can take, how to detect it, and how it is treated?
Stay updated with breaking news from Valvular Heart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
What should patients know about valvular heart disease, the forms it can take, how to detect it, and how it is treated?
/PRNewswire/ -- The "China TAVR & TMV Market: Insights & Forecast (2022-2026)" report has been added to ResearchAndMarkets.com's offering. The Chinese TAVR...
/PRNewswire/ -- The "China TAVR & TMV Market: Insights & Forecast (2022-2026)" report has been added to ResearchAndMarkets.com's offering. The Chinese TAVR...
If you're having trouble breathing, there are many things that could be wrong with your heart. It could happen all at once or over time. It can also
April 12, 2021 Physicians should aim to use the least amount of antithrombotic therapy as possible in their patients undergoing TAVI, according to a new European consensus statement. In general, over the long term, patients should be on monotherapy with an oral anticoagulant if they have an indication for it—like atrial fibrillation (AF)—or with low-dose aspirin if they don’t, according to a group led by Jurriën ten Berg, MD, PhD (St. Antonius Hospital, Nieuwegein, the Netherlands). They advise some type of dual therapy in the first 1 to 6 months for patients who have undergone recent ...